Momenta Pharm., Inc. v. Amphastar Pharm., Inc.

570 U.S. 917, 186 L. Ed. 2d 909, 133 S. Ct. 2854, 81 U.S.L.W. 3700, 2013 WL 655193, 2013 U.S. LEXIS 4763
CourtSupreme Court of the United States
DecidedJune 24, 2013
DocketNo. 12–1033.
StatusPublished

This text of 570 U.S. 917 (Momenta Pharm., Inc. v. Amphastar Pharm., Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Momenta Pharm., Inc. v. Amphastar Pharm., Inc., 570 U.S. 917, 186 L. Ed. 2d 909, 133 S. Ct. 2854, 81 U.S.L.W. 3700, 2013 WL 655193, 2013 U.S. LEXIS 4763 (2013).

Opinion

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
570 U.S. 917, 186 L. Ed. 2d 909, 133 S. Ct. 2854, 81 U.S.L.W. 3700, 2013 WL 655193, 2013 U.S. LEXIS 4763, Counsel Stack Legal Research, https://law.counselstack.com/opinion/momenta-pharm-inc-v-amphastar-pharm-inc-scotus-2013.